LCNB Corp. reports record $7.5 million second quarter profit
LCNB Corp. (NASDAQ:LCNB) reported a record second-quarter net income of $7.5 million and earnings of $0.53 per share for the three months ended June 30.
LCNB Corp. (NASDAQ:LCNB) reported a record second-quarter net income of $7.5 million and earnings of $0.53 per share for the three months ended June 30.
Moderna (NASDAQ:MRNA) dosed the first U.S. participant in its Phase 1 trial evaluating the mRNA-4200 cancer antigen therapy.
Main Street Capital (NYSE:MAIN) projected second-quarter distributable net investment income between $1.02 and $1.06 per share.
Horizon Aircraft (NASDAQ:HOVR) reported fiscal 2026 fourth-quarter results, highlighting a strengthened cash balance of $78.3 million.
Merck (NYSE:MRK) received FDA approval for Lipfendra 20 mg after a Phase 3 trial showed a 56% LDL-C reduction versus placebo.
U.S. Bancorp (NYSE:USB) reported Q1 2026 net revenue of $7.288 billion and diluted EPS of $1.18, exceeding the $1.14 analyst estimate.
Eli Lilly (NYSE:LLY) executed a definitive agreement to acquire AtaiBeckley (NASDAQ:ATAI) for a $2.8 billion upfront equity valuation.
Tether, the world's largest stablecoin issuer by market capitalisation, has invested US$20 million in Argentine digital bank Ualá as part of a broader push to expand its presence across South America.
AtaiBeckley (NASDAQ:ATAI) shares jumped about 50% after Bloomberg reported that Eli Lilly (NYSE:LLY) could acquire the psychedelic drug developer this week.
Insteel (NYSE:IIIN) reported $197.7 million in net sales and $9 million in net earnings for the third quarter of fiscal 2026.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas